This is the misunderstanding that shapes everything else.
Melatonin is made by the pineal gland on a daily rhythm, low in daylight and rising at night. That rhythm is set by the suprachiasmatic nucleus, the master clock in your brain, which itself is entrained by light. Melatonin then feeds back onto that clock. It acts at two receptors, MT1 and MT2, which reduce firing in the clock nucleus and shift its phase.
So the primary, best-evidenced action of melatonin is telling your body what time it is, not knocking you out. This is why the timing of a dose matters more than its size, and why the strongest evidence for melatonin is in situations where your internal clock is misaligned with the outside world.
The jet lag evidence is genuinely good. A Cochrane review of ten trials found nine showed melatonin taken close to target bedtime reduced jet lag after flights crossing five or more time zones, with a number needed to treat of 2. That is a strong result by any standard.
This is the most practically useful thing on this page.
The dose at which melatonin’s physiological effect was demonstrated is around 0.3 mg. In one study, 0.3 mg restored sleep efficiency as well as 3 mg did, while the 3 mg dose produced hypothermia and left melatonin circulating into the following day. Cochrane found doses above 5 mg no more effective for jet lag, and no dose response at all across 1 to 10 mg for shift work.
US retail melatonin is commonly sold at 5 mg and 10 mg. That is fifteen to thirty times the dose at which the effect was shown, with no efficacy justification and a documented daytime carryover penalty.
There is a second problem. An analysis of 31 commercial melatonin supplements using UPLC found actual content ranging from 83 percent below the label to 478 percent above it, and more than 71 percent of products failing to meet their label within a 10 percent margin.
If you take melatonin, the evidence points towards a low dose taken at a consistent time rather than a high one.
Combination products are common. Two things are worth knowing.
CBD inhibits several cytochrome P450 enzymes. Melatonin is metabolized primarily by CYP1A2, which CBD affects less than the enzymes it strongly inhibits, so the interaction risk here is lower than for many drug combinations. But if you take other medication, the CBD half of the product is the part to raise with your prescriber.
Separately, if the product also contains CBN, preclinical work published in 2025 suggests a CBN and melatonin interaction that has not been characterized in people.
For everyday sleep, the numbers are smaller than the marketing suggests.
CBD’s sleep evidence is thinner than melatonin’s, not thicker.
Melatonin is not useless. It is useful for a narrower set of problems than it is sold for.
Still weighing up the options? See CBN vs CBD or Reishi vs ashwagandha. For more background, read our guide on CBD for sleep. Endoca products related to this comparison: Natural melatonin with CBN and CBG and CBD sleep products.
Melatonin is sold as a dietary supplement and is widely available. Note that this is unusual internationally; in much of Europe it is a prescription medicine at therapeutic doses.
CBD’s position is more complicated. Hemp-derived CBD is not a controlled substance under the 2018 Farm Bill, but FDA holds that CBD cannot lawfully be a dietary supplement ingredient or added to food, because it was approved as a drug first. From 12 November 2026 the federal hemp definition changes to a total THC test with a 0.4 mg per container cap on finished products.
Our sleep-positioned products state the exact milligram content of every active ingredient on the label and on the batch certificate of analysis. Given the published finding that most melatonin supplements miss their own label by more than 10 percent, a verifiable number is the most useful thing a brand can offer in this category.
They are commonly combined. No specific interaction problem is documented between them, though CBD does affect drug-metabolising enzymes generally.
Melatonin has the better evidence, and that evidence shows a small effect best suited to circadian problems like jet lag rather than to insomnia.
The evidence points to 0.3 to 1 mg rather than the 5 or 10 mg commonly sold.
Timing matters more than dose. Close to your target bedtime for sleep onset, and for jet lag, close to bedtime at your destination.
It is not considered habit-forming. Long-term safety data are limited, which is a different question.
No. Melatonin is a timing signal: it tells the body clock that night has started. That is why timing matters more than dose, and why it helps most with jet lag and shifted sleep schedules.
It depends on the country. Melatonin is sold over the counter as a supplement in the US, but in the UK and much of Europe higher-dose products are prescription medicines.
Ferracioli-Oda E, Qawasmi A, Bloch MH. Meta-Analysis: Melatonin for the Treatment of Primary Sleep Disorders. PLoS ONE 2013;8:e63773.
Sateia MJ et al. Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults. J Clin Sleep Med 2017;13:307-349.
Herxheimer A, Petrie KJ. Melatonin for the prevention and treatment of jet lag. Cochrane Database Syst Rev 2002.
Liira J et al. Pharmacological interventions for sleepiness and sleep disturbances caused by shift work. Cochrane Database Syst Rev 2014.
Fatemeh G et al. Effect of melatonin supplementation on sleep quality. J Neurol 2022;269:205-216.
Liu J et al. MT1 and MT2 Melatonin Receptors. Annu Rev Pharmacol Toxicol 2016;56:361-383.
Last reviewed 1 September 2026.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.